Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK/STAT signaling in hematological malignancies
William Vainchenker, Stefan N. Constantinescu
Oncogene (2012) Vol. 32, Iss. 21, pp. 2601-2613
Open Access | Times Cited: 477

Showing 1-25 of 477 citing articles:

The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
Sally Thomas, John A. Snowden, Martin P. Zeidler, et al.
British Journal of Cancer (2015) Vol. 113, Iss. 3, pp. 365-371
Open Access | Times Cited: 572
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
Elisa Rumi, Daniela Pietra, Virginia Valeria Ferretti, et al.
Blood (2013) Vol. 123, Iss. 10, pp. 1544-1551
Open Access | Times Cited: 549
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker, Róbert Královics
Blood (2016) Vol. 129, Iss. 6, pp. 667-679
Open Access | Times Cited: 531
The genetics and mechanisms of T cell acute lymphoblastic leukaemia
Laura Belver, Adolfo A. Ferrando
Nature reviews. Cancer (2016) Vol. 16, Iss. 8, pp. 494-507
Closed Access | Times Cited: 404
Genomic landscape of cutaneous T cell lymphoma
Jaehyuk Choi, Gerald Goh, Trent Walradt, et al.
Nature Genetics (2015) Vol. 47, Iss. 9, pp. 1011-1019
Open Access | Times Cited: 385
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
Ilyas Chachoua, C. Pecquet, Mira El-Khoury, et al.
Blood (2015) Vol. 127, Iss. 10, pp. 1325-1335
Open Access | Times Cited: 300
Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Bernd Groner, Viktoria von Manstein
Molecular and Cellular Endocrinology (2017) Vol. 451, pp. 1-14
Closed Access | Times Cited: 272
T-cell acute lymphoblastic leukemia
Elizabeth A. Raetz, David T. Teachey
Hematology (2016) Vol. 2016, Iss. 1, pp. 580-588
Open Access | Times Cited: 253
Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium
Chilaluck C. Konkankit, Sierra C. Marker, Kevin M. Knopf, et al.
Dalton Transactions (2018) Vol. 47, Iss. 30, pp. 9934-9974
Closed Access | Times Cited: 244
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Uddalak Bharadwaj, Moses M. Kasembeli, Prema Robinson, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 2, pp. 486-526
Open Access | Times Cited: 238
The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects
Farhad Dehkhoda, Christine M. M. Lee, Johan Medina, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 228
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib
Paqui G. Través, Bernard P. Murray, Federico Campigotto, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 7, pp. 865-875
Open Access | Times Cited: 221
Structure of the pseudokinase–kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition
Patrick J. Lupardus, Mark Ultsch, Heidi J.A. Wallweber, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 22, pp. 8025-8030
Open Access | Times Cited: 197
The regulation of JAKs in cytokine signaling and its breakdown in disease
Henrik M. Hammarén, Anniina Virtanen, Juuli Raivola, et al.
Cytokine (2018) Vol. 118, pp. 48-63
Open Access | Times Cited: 186
Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations
Stephan Wilmes, Maximillian Hafer, Joni Vuorio, et al.
Science (2020) Vol. 367, Iss. 6478, pp. 643-652
Open Access | Times Cited: 156
SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer
Mohamed Luban Sobah, Clifford Liongue, Alister C. Ward
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 122
JAK inhibitors and autoimmune rheumatic diseases
Maurizio Benucci, Pamela Bernardini, Carmela Coccia, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103276-103276
Open Access | Times Cited: 65
miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance– An emphasis on the interaction of signaling pathways
Ahmed S. Doghish, Ahmed I. Abulsoud, Shereen Saeid Elshaer, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154363-154363
Closed Access | Times Cited: 57
miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay
Shereen Saeid Elshaer, Ahmed I. Abulsoud, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154511-154511
Closed Access | Times Cited: 56
The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy
Mohamed Bakr Zaki, Ahmed I. Abulsoud, Shereen Saeid Elshaer, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154437-154437
Closed Access | Times Cited: 48
Smoking‐Induced M2‐TAMs, via circEML4 in EVs, Promote the Progression of NSCLC through ALKBH5‐Regulated m6A Modification of SOCS2 in NSCLC Cells
Cheng Cheng, Peiwen Wang, Yi Yang, et al.
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 42
Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management
Ayalew Tefferi, Alessandro M. Vannucchi, Tiziano Barbui
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 697-718
Open Access | Times Cited: 42
Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
JAK-STAT signaling maintains homeostasis in T cells and macrophages
Nikolaus Fortelny, Matthias Farlik, Victoria Fife-Gernedl, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 847-859
Open Access | Times Cited: 27
JAK/STAT Pathway in Drosophila Immunity
Henna Myllymäki, Mika Rämet
Scandinavian Journal of Immunology (2014) Vol. 79, Iss. 6, pp. 377-385
Closed Access | Times Cited: 180
Page 1 - Next Page

Scroll to top